TMC Life Sciences Berhad (KLSE:TMCLIFE)
0.4150
+0.0150 (3.75%)
At close: Nov 20, 2026
| Market Cap | 722.88M -1.2% |
| Revenue (ttm) | 393.03M +13.7% |
| Net Income | 17.38M +382.0% |
| EPS | 0.01 +382.0% |
| Shares Out | 1.74B |
| PE Ratio | 41.60 |
| Forward PE | n/a |
| Dividend | 0.01 (1.39%) |
| Ex-Dividend Date | Dec 8, 2026 |
| Volume | 91,000 |
| Open | 0.4000 |
| Previous Close | 0.4000 |
| Day's Range | 0.4000 - 0.4150 |
| 52-Week Range | 0.4000 - 0.5750 |
| Beta | 0.31 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 24, 2026 |